Ionis Pharma (NASDAQ: IONS) reported Q3 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $120.9 million versus the consensus estimate of $116.96 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.